Yasameen Abbas Humadi

Yasameen Abbas Humadi
Al-Nahrain University · Department of Medicine

Doctor of Medicine

About

15
Publications
1,878
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
6
Citations
Additional affiliations
July 2021 - present
Baghdad Medical City
Position
  • physician

Publications

Publications (15)
Article
Full-text available
Background There is a growing interest in studying the effects of arthritis on a person's work productivity using a growing variety of outcome indicators. Objectives To develop a valid and reliable shortened version of the Workplace Activity Limitation Scale 12 (WALS-12) for assessing work productivity limitations in rheumatoid arthritis (RA) pati...
Article
Full-text available
Background: Both of chronic inflammation and mineral disturbance are major concerns in patients with chronic kidney disease, particularly end-stage renal disease (ESRD). Objectives: The present study aimed to investigate the association between circulating IL-6 and minerals dysregulation in patients diagnosed with ESRF and on a continuous hemodialy...
Poster
Full-text available
Background Sialosis is a non inflammatory nor neoplastic expansion of the salivary glands. it is a common mimicker for obstructive, inflammatory and malignant salivary gland disorders.(1) It had been described in acromegaly, vitamin A, and Thiamin deficiency and in amylophagia and bulimia.(2-5) Imaging should be normal in Sialosis(6) Here we descri...
Article
Full-text available
BACKGROUND: Cytokines are inflammatory mediators that regulate multiple processes potentially implicated in inflammation and autoimmunity. AIM: This study aimed to investigate the levels of circulating interleukin (IL)-35, IL-36, and IL-35/IL-36 ratio in Juvenile Idiopathic Arthritis (JIA) patients. METHODS: Fifty-one patients categorized based on...
Article
Full-text available
Purpose: The development of evidence-based guidelines on early pharmacotherapeutic treatment of rheumatoid arthritis (RA) could be useful in Middle Eastern nations striving to improve outcomes in patients with this chronic, debilitating disease. Evidence obtained from local populations should inform such guidelines and therefore our aim was to use...
Article
Full-text available
Background/Purpose: The management of patients with early rheumatoid arthritis (RA), defined by the American College of Rheumatology (ACR) guidelines as patients who have had RA disease or symptoms for < 6 months, can improve prognosis and long-term clinical outcomes and reduce joint damage. In the Middle East, available evidence suggests that the...
Article
Full-text available
Background: The current crisis COVID-19 has affected the already challenging management of rheumatic diseases. Since no evidence-based approach is yet available, this survey was conducted to explore the Iraqi rheumatologists' attitude in the era of COVID-19 and how they have been managing their patients, especially with the continuously updating a...
Article
Full-text available
Recommendation to practicing physicians on the management of patients with rheumatic conditions
Article
Full-text available
Background: Fibromyalgia is a functional disorder of growing importance characterized by chronic widespread musculoskeletal pain. It frequently affects women of child bearing age. Infertility is failure to achieve pregnancy within a 12 month period for sexually active individuals under 35 years of age and failure to conceive within a 6 months perio...
Article
Full-text available
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disorder affecting mainly young women during childbearing years. OBJECTIVE: To assess the prevalence of cervical dysplasia in a group of Iraqi women with SLE and study the relationship between results of Pap smear and HPV DNA test with disease activity, disease durat...
Article
Full-text available
Biologic therapies are an important option in the treatment of patients with rheumatic disease. As the development of potential biosimilars increases, many countries are following the guidelines developed by the WHO, European Medicines Agency, or US Food and Drug Administration to create country-specific regulations for the review and approval of t...
Article
Full-text available
Purpose of review: Biosimilars are of growing importance worldwide, and many leading countries are introducing them in their health care systems and are using them in many fields of medicine owing to their low price tags in comparison with the brands and to their similarities in terms of function and side effects. So we cannot look past them and c...

Network

Cited By